Smell Abnormalities Caused by Sars-Cov2 Infection:  A Literary Review

Vit#xF3;ria F. Silva; Andrey Modesto Velasquez Lins; Beatriz Cid de Matos; Agust#xED;n Miguel Rodrigues

Authors

Vit#xF3;ria F. Silva
Andrey Modesto Velasquez Lins
Beatriz Cid de Matos
Agust#xED;n Miguel Rodrigues

Keywords:

SARS-COV2; anosmia; neurons

Abstract

Abstract not found

Downloads

How to Cite

Smell Abnormalities Caused by Sars-Cov2 Infection: A Literary Review. (2022). Global Journal of Medical Research, 22(F1), 11. https://medicalresearchjournal.org/index.php/GJMR/article/view/2640

Download Citation

References

Bianca Pimentel (2020) As disfunções olfativas e gustativas como apresentação clínica da COVID-19. 9(8), e64985072.

D Rann (2020) Non-neuronal expression of SARS-CoV-2 entry genes in the olfatory system suggests mechanisms underlying COVID-19associated anosmia. 5801.

Hao Xu, Liang Zhong, Jiaxin Deng, Jiakuan Peng, Hongxia Dan, Xin Zeng, Taiwen Li, Qianming Chen (2020) High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. 12(1).

Jenny Meinhardt, Josefine Radke, Carsten Dittmayer, Ronja Mothes, Jonas Franz, Michael Laue, Julia Schneider, Sebastian Brünink, Olga Hassan, Werner Stenzel, Marc Windgassen, Larissa Rößler, Hans-Hilmar Goebel, Hubert Martin, Andreas Nitsche, Walter Schulz-Schaeffer, Samy Hakroush, Martin Winkler, Björn Tampe, Sefer Elezkurtaj, David Horst, Lars Oesterhelweg, Michael Tsokos, Barbara Heppner, Christine Stadelmann, Christian Drosten, Victor Corman, Helena Radbruch, Frank Heppner (2021) Olfactory transmucosal SARS-CoV-2 invasion as port of Central Nervous System entry in COVID-19 patients. 24.

R Butowt (2021) The olfactory nerve is not a likely route to brain infection in COVID-19: a critical review of a data from humans and animal models.

Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche, Marcel Müller, Christian Drosten, Stefan Pöhlmann (2020) SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. 181(2), 271-280.e8.